(6S,12R,18S,21S,23aS,29S,32S,35S,37aS)-18-(4-aminobutyl)-6,29-dibenzyl-32-sec-butyl-21-(3-guanidinopropyl)-35-isobutyl-5,8,14,17,20,23,28,31,34,37-decaoxohexatriacontahydrodipyrrolo[2,1-a₁:2',1'-o][1,4,7,10,13,16,19,22,25,28,31]thiadecaazacyclotritriacontine-12-carboxamide

ID: ALA4846940

Chembl Id: CHEMBL4846940

PubChem CID: 164609154

Max Phase: Preclinical

Molecular Formula: C59H89N15O11S

Molecular Weight: 1216.52

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)CSC[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC1=O

Standard InChI:  InChI=1S/C59H89N15O11S/c1-5-36(4)49-56(83)71-43(31-38-19-10-7-11-20-38)58(85)74-28-15-23-45(74)54(81)69-40(22-14-26-64-59(62)63)52(79)68-39(21-12-13-25-60)51(78)65-32-47(75)67-44(50(61)77)33-86-34-48(76)66-42(30-37-17-8-6-9-18-37)57(84)73-27-16-24-46(73)55(82)70-41(29-35(2)3)53(80)72-49/h6-11,17-20,35-36,39-46,49H,5,12-16,21-34,60H2,1-4H3,(H2,61,77)(H,65,78)(H,66,76)(H,67,75)(H,68,79)(H,69,81)(H,70,82)(H,71,83)(H,72,80)(H4,62,63,64)/t36-,39-,40-,41-,42-,43-,44-,45-,46-,49-/m0/s1

Standard InChI Key:  VRTKHRWCUDMOKP-GLMWGEBZSA-N

Alternative Forms

1. Parent:

   

   ALA4846940

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1216.52

Molecular Weight (Monoisotopic): 1215.6587

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Hayashi K, Uehara S, Yamamoto S, Cary DR, Nishikawa J, Ueda T, Ozasa H, Mihara K, Yoshimura N, Kawai T, Ono T, Yamamoto S, Fumoto M, Mikamiyama H..  (2021)  Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell.,  12  (7.0): [PMID:34267879] [10.1021/acsmedchemlett.1c00134]

Source

Source(1):

• Scientific Literature